Search
Arcus Biosciences Inc
RCUSAdd to Watchlist
25.240USD
-0.300-1.17%
Close 09-18 16:00（ET）
3.21BMarket Cap
LossP/E TTM
After-hours 19:00 (ET)25.240USD+0.030+0.12%
After-hours 19:00 (ET)TradingKey Chart
Intraday
1m
30m
1h
D
W
M
D
Today
-1.17%
5 Days
+2.64%
1 Month
-14.47%
6 Months
+13.64%
Year to Date
+5.92%
1 Year
+102.89%
Key Figures
25.740Open
25.740High
244.60KVolume
LossP/E TTM
LossP/E Dynamic
--Dividend TTM
0.19%Turnover Ratio
25.540Prev. Close
25.020Low
6.24MTurnover
LossP/E Static
6.92P/B
0.00%Div Yield TTM
-34.28%ROA
31.73552wk High
0.10Volume Ratio
-283.00MNet Profit
127.00MShares
-3.1693EPS TTM
0.84Beta
-69.95%ROE
12.11352wk Low
2.82%Amplitude
100.00%Gross Margin
3.21BMarket Cap
1.34Reward/Risk
3.90%Risk Rate
Arcus Biosciences Inc's Score
0.10vs previous score
Forecast8.00
Financial Health7.10
Technical5.05
Valuation Dimensions7.38
Institutional Confidence7.00
Risk Assessment5.80
Media Coverage
Coverage Level
Very Low
Very High
Positive
Analyst Rating
Arcus Biosciences Inc Technical Analysis
Technical Indicators
Sell
Summary
Sell
Moving Average
Sell
Financial Indicators
Relevant data have not been disclosed by the company yet.
Relevant data have not been disclosed by the company yet.
Earnings
Next reporting date
--
Reporting Period
2026Q2
Earnings / Forecast
-0.72/-0.90
Revenue / Forecast
41.00M/23.41M
Arcus Biosciences Inc Profile
SectorBiotechnology & Medical Research
Ticker SymbolRCUS
Number of employees627
CountryUnited States of America
Ownership
| Shareholders | Proportion |
|---|---|
| Gilead Sciences, Inc | 24.99% |
| BlackRock Institutional Trust Company, N.A. | 9.67% |
| Suvretta Capital Management, LLC | 4.13% |
| Wellington Management Company, LLP | 4.12% |
| Shareholder Types | Proportion |
|---|---|
| Investment Advisor | 28.35% |
| Corporation | 24.99% |
| Investment Advisor/Hedge Fund | 22.42% |
| Hedge Fund | 17.59% |
Related Instruments
+0.04%
-0.09%
-0.04%
-0.02%
-0.19%
-0.39%
+1.55%
-0.52%
+0.07%
+0.12%
+0.35%
-1.55%
-1.65%
-1.53%
-0.56%
-0.58%
-0.55%
-2.55%
-0.73%
-0.42%Popular Instruments
51734.000
-26.000 (-0.05%)
29664.700
+252.000 (+0.86%)
7659.100
+27.000 (+0.35%)
14420.000
+119.000 (+0.83%)
65079.000
+130.000 (+0.20%)
6230.800
-76.400 (-1.21%)
96.001
-1.985 (-2.03%)
336.130
-0.870 (-0.26%)
222.270
+2.930 (+1.34%)
4377.330
+36.350 (+0.84%)
FAQs
What is the current price of Arcus Biosciences Inc (RCUS)?
The current price of Arcus Biosciences Inc (RCUS) is 25.24.
What is the symbol of Arcus Biosciences Inc?
The ticker symbol of Arcus Biosciences Inc is RCUS.
What is the 52-week high of Arcus Biosciences Inc?
The 52-week high of Arcus Biosciences Inc is 31.73.
What is the 52-week low of Arcus Biosciences Inc?
The 52-week low of Arcus Biosciences Inc is 12.11.
What is the market capitalization of Arcus Biosciences Inc?
The market capitalization of Arcus Biosciences Inc is 3.21B.
Is Arcus Biosciences Inc (RCUS) currently rated as Buy, Hold, or Sell?
According to analysts, Arcus Biosciences Inc (RCUS) has an overall rating of Buy, with a price target of 38.75.
What is the Earnings Per Share (EPS TTM) of Arcus Biosciences Inc (RCUS)?
The Earnings Per Share (EPS TTM) of Arcus Biosciences Inc (RCUS) is -3.17.